The effect of Descurainia Sophia on neonatal jaundice

Comparison the effect of Descurainia sophia and placebo consumed by the mother in the last 6 weeks of pregnancy with Placebo on total and direct bilirubin levels in cord blood The last 6 weeks of pregnancy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201405253078N11

Enrollment

100

Registered

2014-08-07

Start date

2014-08-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Jaundice. Neonatal jaundice from other and unspecified causes

Interventions

Intervention 1: The intervention group will recieve 10 grams of Descurainia sophia in 250 cc of water and sugar twice a day from 34 weeks of gestation to time of delivery. After birth, the amount of

Prevention

Treatment - Drugs

The intervention group will recieve 10 grams of Descurainia sophia in 250 cc of water and sugar twice a day from 34 weeks of gestation to time of delivery. After birth, the amount of total and direc

The control group will receive a placebo (250 cc water and sugar) twice a day from 34 weeks of gestation to time of delivery. After birth, the amount of total and direct bilirubin levels in cord blood

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion criteria : Nulliparity; having a diploma or higher Exclusion criteria : Incompatibility of RH; familial history of hemolysis in parents; G6PD difitiency

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Total bilirubin levels in cord blood. Timepoint: At Birth. Method of measurement: Cord blood samplying.;Direct bilirubin levels in cord blood. Timepoint: At Birth. Method of measurement: Cord blood samplying.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasoumeh Delaram

Shahrekord University of Medical Sciences

masoumehdelaram@yahoo.com+98 38 1333 5648

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026